D-1038-2017 Class III Terminated
FDA drug recall D-1038-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Jul 11, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220. The recall status is terminated (terminated Apr 1, 2019). Affected quantity: 544 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 9, 2017
- Initiation Date
- Jul 11, 2017
- Termination Date
- Apr 1, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 544 bottles
Product description
Pravastatin Sodium Tablets, USP, 10 mg, packaged in a) 90-count bottles (NDC 55111-229-90) and b) 500-count bottles (NDC 55111-229-05), Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA; Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA.
Reason for recall
Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.
Distribution pattern
Nationwide in the USA
Code information
Lot #: a) C700220, Exp 06/18; b) C700220, Exp 06/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1038-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026